InsiderClue
Stocks · Health care · Pharmaceutical Preparations

OnKure Therapeutics, Inc.

OKUR Clue Score34
United States Fiscal year ends December CIK 0001637715 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Jason A. Leverone
21 Sep 2026
Chief Financial Officer
Sell
302
$2.97
$898.21
Nicholas A Saccomano
21 Sep 2026
President and CEO
Sell
87
$2.97
$258.76
Jason A. Leverone
22 Jun 2026
Chief Financial Officer
Sell
303
$4.40
$1.33K
Nicholas A Saccomano
22 Jun 2026
President and CEO
Sell
86
$4.40
$378.08
Jason A. Leverone
23 Mar 2026
Chief Financial Officer
Sell
301
$4.16
$1.25K
Nicholas A Saccomano
23 Mar 2026
President and CEO
Sell
86
$4.16
$357.46
Jason A. Leverone
22 Dec 2025
Chief Financial Officer
Sell
302
$2.97
$896.25
Nicholas A Saccomano
22 Dec 2025
President and CEO
Sell
87
$2.97
$258.19
Show all 8 transactions →

What was left out

Form 4 filings counted 32
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 9,169
History held since 12 Apr 2021